Long After 5 Years of Hormonal Therapy Ends, Risk of Recurrence May Still Be Significant
A study found women with hormone receptor-positive early-stage breast cancer had a 10 to 41 percent risk of developing metastatic breast cancer in the 20 years after their diagnosis, despite standard hormonal therapy